Cybin Establishes Clinical Advisory Board of Renowned Physicians
Cybin Inc. today announced the formation of its Clinical Advisory Board.
Ehave to Launch Ketamine Trials Using Brain Mapping Technology
Ehave, Inc. announced plans to launch brain mapping ketamine clinical trials using Brain Scientific technology later this year.
Silo Wellness Announces Intellectual Property Licensing Agreement of Psilocybin Nasal Spray in Colombia and Brazil
Quick Take: Silo Wellness entered into an agreement with Jungle Med to distribute and sell their psilocybin nasal spray in Colombia and Brazil. Silo Wellness Inc. (SILO), a wellness company in the psychedelics and functional mushroom marketplaces announced today that through its wholly-owned subsidiary, it has signed a binding Letter of Intent (LOI) for a […]
Mindset Pharma Announces Closing of $7.5 Million Bought Deal Public Offering
Mindset Pharma Inc. announced that it has completed the previously announced “bought deal” public offering through the issuance of an aggregate of 10,000,000 units of the company at a price of $0.75 per unit for aggregate gross proceeds to the company of $7,500,000.